Comparison of efficacy and toxicity between nedaplatin and cisplatin in treating malignant pleural effusion
Li-Zhe Zhong,1 Hong-Yan Xu,2 Zhong-Min Zhao,3 Guang-Mei Zhang,2 Feng-Wu Lin4 1Department of Cardiothoracic Surgery, Affiliated Hospital of Beihua University, Jilin, China; 2Department of Medical Oncology, The Second Hospital of Jilin, Jilin, China; 3Department of Pain, Jilin City Central Hospital,...
Main Authors: | Zhong LZ, Xu HY, Zhao ZM, Zhang GM, Lin FW |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-09-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/comparison-of-efficacy-and-toxicity-between-nedaplatin-and-cisplatin-i-peer-reviewed-article-OTT |
Similar Items
-
Diagnostic value of calprotectin in differentiation between benign and malignant pleural effusion
by: Omar M. Mohammed, et al.
Published: (2019-07-01) -
Accuracy of closed pleural biopsy in the diagnosis of malignant pleural effusion
by: Renata Báez-Saldaña, et al. -
Evaluation of pleural fluid YKL-40 as a marker of malignant pleural effusion
by: Adel Attia, et al.
Published: (2015-04-01) -
Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions
by: Abdel-sadek Hamed Al-aarag, et al.
Published: (2019-06-01) -
Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion
by: Chen KY, et al.
Published: (2016-06-01)